Net profit increased 9.4% year-over-year to €624 million, with premiums up 1.1% and strong Non-Life performance. ROE reached 12.5%, and shareholders' equity rose to €9.6 billion. The upcoming U.S. acquisition is expected to further boost results.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.